To read the original article in full go to : New obesity figures highlight the income divide.
Below is a short summary and detailed review of this article written by FutureFactual:
England's obesity crisis widens the wealth gap as environment, policy and private drug access shape outcomes
Summary
New obesity figures for England show a substantial rise to 30 percent of adults obese by 2025, with the fastest increases among people in their 20s and 30s and stark disparities across income and geography. The analysis links weight gain to environmental factors such as cheap processed foods and car-centered living and notes that policy efforts have only just begun to reshape the obesogenic environment. It also highlights a structural divide in access to weight-loss medicines, which are largely paid for privately and may widen the gap between rich and poor. Originally published by The Conversation.
- Obesity rose from 26% in 2019 to 30% in 2025; nearly one in three adults obese.
- Young adults show the sharpest increases; poverty amplifies diagnoses and intergenerational risk.
- Private access to GLP-1 weight-loss drugs dominates; NHS access is rationed, potentially widening inequality.
- Policy steps target the environment but may be insufficient to reverse decades of obesity drivers.
Overview
New obesity figures highlight a widening crisis in England, with obesity increasing from 26% in 2019 to 30% in 2025, according to an analysis of about 55 million people. Almost one in three adults are now obese. The data reveal two diverging trends: a rapid rise among younger adults and a pronounced income-based divide, where new diagnoses are about 35% more common in the poorest fifth of the country than the richest. The gaps are larger among women and Asian women, and even within regions there are stark contrasts, such as high obesity rates in parts of the north-east and very low rates in central London’s wealthier pockets. The National Child Measurement Programme shows similar patterns in children by year six, with obesity more than twice as common in poorer neighbourhoods than in wealthier ones, and a growing gap in severe obesity. Original publication: The Lancet analysis referenced by The Conversation.
Two driving patterns behind rising obesity
The article argues that weight gain results from the environment in which people live, including the availability and marketing of cheap processed foods and urban design that favours car travel over walking or cycling. These conditions disproportionately affect poorer areas that have more fast food outlets, fewer parks, and less time or money for healthier choices. Willpower alone cannot counteract an environment built over decades, especially for younger generations who have grown up in this context.
Geography and social inequality
New obesity diagnoses are notably more common in the poorest fifth of the population, and the gap widens for women and for Asian women. In the north-east, nearly half of adults are obese, while central London’s wealthier areas show obesity rates under 10%. The year six measurements show similar divides among children, with the poorest areas reporting 29% obesity versus 14% in the wealthiest areas—an even larger gap for severe obesity.
Policy responses and the obesity environment
Policy responses in the UK have shifted toward environmental interventions rather than individual blame. Since January, junk food adverts have been banned online and restricted on TV before 9pm, and buy-one-get-one-free deals for unhealthy foods have been prohibited. While these steps are welcomed, they are early moves and insufficient to undo the environmental patterns that have formed over decades.
Weight-loss medicines and access inequality
Drugs such as Mounjaro and Wegovy can be effective for weight loss, but access in the UK remains highly unequal. About 90% of people taking these drugs pay privately, at roughly £130 to £350 per month, equating to more than £3,000 per year. Health Foundation data show that people in the least deprived areas are more than twice as likely to be taking one of these drugs as those in the most deprived areas. The NHS route for obesity medicines is tightly rationed and prioritises medical need and waiting times, meaning those with wealth are better positioned to benefit.
Conclusion and implications
The article argues that England faces two obesity problems simultaneously: a shrinking problem for those who can afford treatment and a growing problem for those who cannot. No drug alone will reverse this trend. Without addressing the fundamental drivers—cheap junk food, aggressive marketing, and neighbourhoods designed around cars rather than people—inequality in obesity outcomes will persist. The piece calls for policies that tackle the environment in which obesity develops and persists, alongside fairer access to effective weight-loss interventions.

